Insiders · CTOR

CTOR insider transactions

Citius Oncology Inc. (CTOR) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for CTOR

• 124d
  Amendment: Chief Medical Officer Czuczman Myron was granted 825,000 shares (SEC Form 4)

  4/A - CITIUS ONCOLOGY, INC. (0001851484) (Issuer)
• 124d
  Amendment: Secretary Holubiak Myron Z was granted 850,000 shares (SEC Form 4)

  4/A - CITIUS ONCOLOGY, INC. (0001851484) (Issuer)
• 124d
  Amendment: Director Webb Carol was granted 300,000 shares (SEC Form 4)

  4/A - CITIUS ONCOLOGY, INC. (0001851484) (Issuer)
• 124d
  Amendment: Chief Financial Officer Bartushak Jaime was granted 825,000 shares (SEC Form 4)

  4/A - CITIUS ONCOLOGY, INC. (0001851484) (Issuer)
• 124d
  Amendment: Director Dutia Suren G was granted 300,000 shares (SEC Form 4)

  4/A - CITIUS ONCOLOGY, INC. (0001851484) (Issuer)
• 124d
  Amendment: Chief Executive Officer Mazur Leonard L was granted 1,700,000 shares (SEC Form 4)

  4/A - CITIUS ONCOLOGY, INC. (0001851484) (Issuer)
• 124d
  Amendment: Director Mayersohn Joel David was granted 300,000 shares, increasing direct ownership by 1,413% to 321,228 units (SEC Form 4)

  4/A - CITIUS ONCOLOGY, INC. (0001851484) (Issuer)
• 124d
  Amendment: Director Smith Robert Joseph was granted 300,000 shares (SEC Form 4)

  4/A - CITIUS ONCOLOGY, INC. (0001851484) (Issuer)
• 124d
  Amendment: Director Mcgrath Dennis M was granted 300,000 shares (SEC Form 4)

  4/A - CITIUS ONCOLOGY, INC. (0001851484) (Issuer)
• 124d
  Amendment: Director Holuka Eugene Myron was granted 300,000 shares (SEC Form 4)

  4/A - CITIUS ONCOLOGY, INC. (0001851484) (Issuer)
• 145d
  Amendment: Director Mayersohn Joel David was granted 300,000 shares, increasing direct ownership by 1,413% to 321,228 units (SEC Form 4)

  4/A - CITIUS ONCOLOGY, INC. (0001851484) (Issuer)
• 145d
  Amendment: Director Holuka Eugene Myron was granted 300,000 shares (SEC Form 4)

  4/A - CITIUS ONCOLOGY, INC. (0001851484) (Issuer)
• 145d
  Amendment: Director Mcgrath Dennis M was granted 300,000 shares (SEC Form 4)

  4/A - CITIUS ONCOLOGY, INC. (0001851484) (Issuer)
• 145d
  Amendment: SEC Form 4/A filed by Citius Oncology Inc.

  4/A - CITIUS ONCOLOGY, INC. (0001851484) (Issuer)
• 145d
  Amendment: Chief Executive Officer Mazur Leonard L was granted 1,700,000 shares (SEC Form 4)

  4/A - CITIUS ONCOLOGY, INC. (0001851484) (Issuer)
• 145d
  Amendment: SEC Form 4/A filed by Citius Oncology Inc.

  4/A - CITIUS ONCOLOGY, INC. (0001851484) (Issuer)
• 145d
  Amendment: Director Dutia Suren G was granted 300,000 shares (SEC Form 4)

  4/A - CITIUS ONCOLOGY, INC. (0001851484) (Issuer)
• 145d
  Amendment: Director Webb Carol was granted 300,000 shares (SEC Form 4)

  4/A - CITIUS ONCOLOGY, INC. (0001851484) (Issuer)
• 145d
  Amendment: Secretary Holubiak Myron Z was granted 850,000 shares (SEC Form 4)

  4/A - CITIUS ONCOLOGY, INC. (0001851484) (Issuer)
• 145d
  Amendment: Chief Medical Officer Czuczman Myron was granted 825,000 shares (SEC Form 4)

  4/A - CITIUS ONCOLOGY, INC. (0001851484) (Issuer)
• 214d
  Chief Medical Officer Czuczman Myron was granted 825,000 shares (SEC Form 4)

  4 - CITIUS ONCOLOGY, INC. (0001851484) (Issuer)
• 214d
  Chief Executive Officer Mazur Leonard L was granted 1,700,000 shares (SEC Form 4)

  4 - CITIUS ONCOLOGY, INC. (0001851484) (Issuer)
• 214d
  Secretary Holubiak Myron Z was granted 950,000 shares (SEC Form 4)

  4 - CITIUS ONCOLOGY, INC. (0001851484) (Issuer)
• 214d
  Director Webb Carol was granted 300,000 shares (SEC Form 4)

  4 - CITIUS ONCOLOGY, INC. (0001851484) (Issuer)
• 214d
  Director Smith Robert Joseph was granted 300,000 shares (SEC Form 4)

  4 - CITIUS ONCOLOGY, INC. (0001851484) (Issuer)
• 214d
  Director Mayersohn Joel David was granted 300,000 shares, increasing direct ownership by 1,413% to 321,228 units (SEC Form 4)

  4 - CITIUS ONCOLOGY, INC. (0001851484) (Issuer)
• 214d
  Director Holuka Eugene Myron was granted 300,000 shares (SEC Form 4)

  4 - CITIUS ONCOLOGY, INC. (0001851484) (Issuer)
• 214d
  Director Dutia Suren G was granted 300,000 shares (SEC Form 4)

  4 - CITIUS ONCOLOGY, INC. (0001851484) (Issuer)
• 214d
  Chief Financial Officer Bartushak Jaime was granted 825,000 shares (SEC Form 4)

  4 - CITIUS ONCOLOGY, INC. (0001851484) (Issuer)
• 214d
  Director Mcgrath Dennis M was granted 300,000 shares (SEC Form 4)

  4 - CITIUS ONCOLOGY, INC. (0001851484) (Issuer)
• 261d
  Director Mayersohn Joel David acquired 21,228 shares (SEC Form 4)

  4 - CITIUS ONCOLOGY, INC. (0001851484) (Issuer)
• 495d
  SEC Form 4 filed by Director Mayersohn Joel David

  4 - CITIUS ONCOLOGY, INC. (0001851484) (Issuer)
• 495d
  SEC Form 4 filed by Director Holuka Eugene Myron

  4 - CITIUS ONCOLOGY, INC. (0001851484) (Issuer)
• 495d
  SEC Form 4 filed by Secretary Holubiak Myron Z

  4 - CITIUS ONCOLOGY, INC. (0001851484) (Issuer)
• 495d
  SEC Form 4 filed by Director Smith Robert Joseph

  4 - CITIUS ONCOLOGY, INC. (0001851484) (Issuer)
• 495d
  SEC Form 4 filed by Director Webb Carol

  4 - CITIUS ONCOLOGY, INC. (0001851484) (Issuer)
• 495d
  SEC Form 4 filed by Director Dutia Suren G

  4 - CITIUS ONCOLOGY, INC. (0001851484) (Issuer)
• 495d
  SEC Form 4 filed by Director Mcgrath Dennis M

  4 - CITIUS ONCOLOGY, INC. (0001851484) (Issuer)
• 495d
  SEC Form 4 filed by Chief Financial Officer Bartushak Jaime

  4 - CITIUS ONCOLOGY, INC. (0001851484) (Issuer)
• 495d
  SEC Form 4 filed by Chief Executive Officer Mazur Leonard L

  4 - CITIUS ONCOLOGY, INC. (0001851484) (Issuer)
• 495d
  SEC Form 4 filed by Chief Medical Officer Czuczman Myron

  4 - CITIUS ONCOLOGY, INC. (0001851484) (Issuer)
• 603d
  Amendment: SEC Form 4 filed by Chief Medical Officer Czuczman Myron

  4/A - CITIUS ONCOLOGY, INC. (0001851484) (Issuer)
• 603d
  Amendment: SEC Form 4 filed by Chief Financial Officer Bartushak Jaime

  4/A - CITIUS ONCOLOGY, INC. (0001851484) (Issuer)
• 603d
  Amendment: SEC Form 4 filed by Chief Executive Officer Mazur Leonard L

  4/A - CITIUS ONCOLOGY, INC. (0001851484) (Issuer)
• 603d
  Amendment: SEC Form 4 filed by Director Holubiak Myron Z

  4/A - CITIUS ONCOLOGY, INC. (0001851484) (Issuer)
• 617d
  SEC Form 4 filed by Director Holuka Eugene Myron

  4 - CITIUS ONCOLOGY, INC. (0001851484) (Issuer)
• 617d
  SEC Form 3 filed by new insider Holuka Eugene Myron

  3 - CITIUS ONCOLOGY, INC. (0001851484) (Issuer)